Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Determine the Concentrations of Raltegravir in Semen, the Seminal to Plasma Ratio of Raltegravir and the Variability in Seminal to Plasma Ratios Over the Raltegravir Dosing Period.

NCT01045265 is registered in ClinicalTrials.gov with Canadian Immunodeficiency Research Collaborative as lead sponsor.

NCT NCT01045265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01045265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Determine the Concentrations of Raltegravir in Semen, the Seminal to Plasma Ratio of Raltegravir and the Variability in Seminal to Plasma Ratios Over the Raltegravir Dosing Period.
Lead sponsor
Canadian Immunodeficiency Research Collaborative
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
July 31, 2012
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv